<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03099863</url>
  </required_header>
  <id_info>
    <org_study_id>IRB15-00769</org_study_id>
    <nct_id>NCT03099863</nct_id>
  </id_info>
  <brief_title>Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Tract Infection</brief_title>
  <official_title>Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Infection: A Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MetroHealth Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MetroHealth Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative urinary tract infections (UTIs) affect 20-30% of patients undergoing elective
      gynecologic surgery and have a significant socioeconomic impact and cost. Preoperative
      antibiotics, sterile operating techniques, postoperative antibiotic and non-antibiotic
      medical therapies have been utilized to attempt to decrease this rate with little
      improvement. Utilization of an intraoperative antibiotic cystoscopic irrigant may decrease
      postoperative UTIs. The investigators have designed a prospective randomized controlled study
      to evaluate the effectiveness of an antibiotic cystoscopic fluid in preventing postoperative
      urinary tract infections in women undergoing elective pelvic floor surgery with cystoscopy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Urinary tract infection</measure>
    <time_frame>4 weeks</time_frame>
    <description>Urinary tract infection defined as positive urinalysis, urine culture, and/or positive lower urinary tract symptoms requiring antibiotic treatment.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">242</enrollment>
  <condition>Urinary Tract Infections</condition>
  <arm_group>
    <arm_group_label>Standard Care</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Standard cystoscopy with normal saline solution.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Neosporin G. U. Irrigant</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard cystoscopy with normal saline solution containing NeosporinÂ® G.U. at a 1mL/1000mL concentration.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cystoscopic Fluid containing Neosporin G. U. Irrigant</intervention_name>
    <description>Normal saline cystoscopic fluid containing Neosporin G. U. Irrigant 1mL/1000mL</description>
    <arm_group_label>Neosporin G. U. Irrigant</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cystoscopy</intervention_name>
    <description>Diagnostic cystoscopy performed during pelvic floor surgery</description>
    <arm_group_label>Standard Care</arm_group_label>
    <arm_group_label>Neosporin G. U. Irrigant</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cystoscopic Fluid/Placebo</intervention_name>
    <description>Normal saline cystoscopic fluid</description>
    <arm_group_label>Standard Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult women at least 18 years of age

          -  Elective Female Pelvic Medicine and Reconstructive Surgery or Gynecologic Minimally
             Invasive surgeries including hysterectomy, suburethral sling, and pelvic organ
             prolapse repair that require cystoscopy.

        Exclusion Criteria:

          -  Surgeries that include: intradetrusor Botox, vaginal mesh excision, and fistula repair

          -  Pregnancy

          -  History of nephrolithiasis

          -  Allergy to study medications

          -  Congenital urogenital anomaly

          -  Neurogenic bladder
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Joseph Henderson, MD</last_name>
    <phone>(216) 778-5890</phone>
    <email>jhenderson3@metrohealth.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jeffrey Mangel, MD</last_name>
    <phone>(216) 778-5890</phone>
    <email>jmangel@metrohealth.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>MetroHealth Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph Henderson, MD</last_name>
      <phone>216-778-5890</phone>
      <email>jhenderson3@metrohealth.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 23, 2017</study_first_submitted>
  <study_first_submitted_qc>April 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2017</study_first_posted>
  <last_update_submitted>April 3, 2017</last_update_submitted>
  <last_update_submitted_qc>April 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>MetroHealth Medical Center</investigator_affiliation>
    <investigator_full_name>Jeffrey Mangel</investigator_full_name>
    <investigator_title>Physician</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Urinary Tract Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination</mesh_term>
    <mesh_term>Bacitracin</mesh_term>
    <mesh_term>Neomycin</mesh_term>
    <mesh_term>Polymyxin B</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

